Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

Aspects of the immunologic treatment of lung cancer.

Alth G, Denck H, Fischer M, Karrer K, Kokron O, Korizek E, Micksche M, Ogris E, Reider C, Titscher R, Wrba H.

Cancer Chemother Rep 3. 1973 Mar;4(2):271-4. No abstract available.

PMID:
4729328
2.

Non-specific immunostimulation in bronchogenic cancer.

Israel L.

Scand J Respir Dis Suppl. 1974;89:95-105. No abstract available.

PMID:
4370224
3.

Initial therapeutic trial of new drugs in lung cancer.

Selawry OS.

Cancer Chemother Rep 3. 1973 Mar;4(2):215-25. No abstract available.

PMID:
4729325
4.

[The immunostate and immunotherapy of primary bronchogenic carcinoma (author's transl)].

Deng WW.

Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi. 1979;2(1):56-8. Chinese. No abstract available.

PMID:
551912
5.

Small-cell bronchogenic carcinoma; advances in treatment.

Bergevin PR.

N Y State J Med. 1980 Nov;80(12):1847-50. No abstract available.

PMID:
6262689
6.

Adjuvant immunotherapy for bronchogenic carcinoma: preliminary results.

Takita H, Brugarolas A.

Cancer Chemother Rep 3. 1973 Mar;4(2):293-8. No abstract available.

PMID:
4729333
7.

Panel report. The surgeon's viewpoint on collaborative research on lung cancer.

Mountain CF.

Cancer Chemother Rep 3. 1973 Mar;4(2):307-9. No abstract available.

PMID:
4125745
8.

Radiotherapy for bronchogenic carcinoma: actual difficulties and plans for the future.

Dana M.

Cancer Chemother Rep 3. 1973 Mar;4(2):153-5. No abstract available.

PMID:
4734076
9.

Some thoughts on surgical adjuvant studies in lung cancer.

Carter SK.

Cancer Chemother Rep 3. 1973 Mar;4(2):109-17. No abstract available.

PMID:
4729314
10.

Adjuvant immunotherapy in bronchogenic carcinoma.

Takita H, Minowada J, Han T, Takada M, Lane WW.

Ann N Y Acad Sci. 1976;277(00):345-54.

PMID:
1069554
11.

Is there a role for immunotherapy in small cell bronchogenic carcinoma?

Israel L.

Recent Results Cancer Res. 1985;97:157-61. Review. No abstract available.

PMID:
2986242
12.

Cytostatic activity of peripheral blood monocytes against bronchogenic carcinoma cells in patients with lung cancer.

Yanagawa E, Yasumoto K, Manabe H, Nagano N, Hirota N, Ohta M, Hattori T, Nomoto K, Azuma I, Yamamura Y.

Gan. 1979 Aug;70(4):533-9.

PMID:
229054
13.

Influence of non-specific immunologic factors on prognosis in advanced bronchogenic carcinoma.

Liberati AM, Voelkel JG, Borden EC, Coates AS, Citrin DL, Bryan GT.

Cancer Immunol Immunother. 1982;13(2):140-4.

PMID:
6961952
14.

Selecting appropriate therapy for bronchial carcinoma.

Shields TW.

Geriatrics. 1974 Jul;29(7):54-60. No abstract available.

PMID:
4835739
15.

[Correlation between immunologic control and prognosis in colo-rectal and pulmonary tumors].

Stipa S, Schillaci A, Modini C.

Minerva Med. 1982 Apr 28;73(18):1145-8. Italian. No abstract available.

PMID:
7078797
16.

Bronchogenic carcinoma: a plea for conservative management.

Patton AJ, Kardinal CG.

Mo Med. 1977 Jan;74(1):19-20, 22, 28. No abstract available.

PMID:
834165
17.

Cyclophosphamide (NSC-26271) as adjuvant to radiotherapy in the treatment of unresectable bronchogenic carcinoma.

Host H.

Cancer Chemother Rep 3. 1973 Mar;4(2):161-4. No abstract available.

PMID:
4729319
18.

Management of small cell bronchogenic carcinoma.

Hansen M.

Compr Ther. 1981 Dec;7(12):22-7. No abstract available.

PMID:
6274582
19.

Bronchogenic carcinoma: immunologic aspects.

Pisani RJ.

Mayo Clin Proc. 1993 Apr;68(4):386-92. Review.

PMID:
8455400
20.

Recent therapeutic developments in lung cancer.

Hansen HH, Selawry OS.

Med Ann Dist Columbia. 1971 Sep;40(9):580-2. Review. No abstract available.

PMID:
4939062
Items per page

Supplemental Content

Write to the Help Desk